| Literature DB >> 32844282 |
Michael Morcos1,2, Christof Burgdorf3, Andrijana Vukadinivikj3, Felix Mahfoud4,5, Joerg Latus6, Pontus B Persson7, Vedat Schwenger6, Andrew Remppis3.
Abstract
Transcatheter aortic valve implantation (TAVI) is an accepted treatment approach of aortic stenosis. In the beginning, this technique was executed in high-risk patients only. Today, intermediate-risk patients are also amenable for TAVI, as long as the transfemoral approach is chosen. Numerous predictors have been identified that could lead to periprocedural complications and are defined by patient co-morbidities as well as being inherent to the technical approach. Although vascular complications and postinterventional paravalvular regurgitation have been minimized over the past years by revised technologies and techniques, there is a prevailing individual risk brought about by the specific pathophysiology of the cardiorenal syndrome.Entities:
Keywords: Aortic valve stenosis; Contrast media; Forced diuresis; Renal insufficiency; Transcatheter aortic valve replacement
Year: 2020 PMID: 32844282 DOI: 10.1007/s00392-020-01732-8
Source DB: PubMed Journal: Clin Res Cardiol ISSN: 1861-0684 Impact factor: 5.460